Home » Topics » Conferences

Conferences
RSS

ELITE II fails to confirm results of ELITE; Merck drops HF indication for Cozaar

Nov. 11, 1999

Insulin sensitizer improves cardiac function in diabetic mice

Nov. 11, 1999

Combined data from three clinical trials of ibritumomab tiuxetan confirm safety in NHL

Nov. 11, 1999

Clinical results for Enbrel in heart failure presented at AHA Scientific Sessions

Nov. 11, 1999

Preclinical and interim clinical data presented for CN-706 at ASTRO

Nov. 11, 1999

Heart Failure: Beyond Y2K -- a Prous Science webcast from the AHA

Nov. 11, 1999

Etanidazole + radiosurgery for brain tumors fails to improve survival compared to radiosurgery alone

Nov. 11, 1999

Prognox effectively detects hypoxic tissue; kinetics differ in stunned and hibernating myocardium

Nov. 11, 1999

News from AHA: photoangioplasty with Antrin is safe and effective for PAD

Nov. 11, 1999

NeXstar research leads to identification of new target for treating renal disease

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...